As reported in Kaiser Health News, the personal drug importation cause had a little victory recently. A bill focused on the opioid crisis, H.R. 6, slated for final passage, includes language that is protective of individuals who import medicines for their own use, even illegally.
H.R. 6 reforms drug importation laws that have nothing to do with opioids but empowers the FDA to stop imports of prescription drugs considered by the FDA to be misbranded (which can mean prescription drugs that have a Canadian not U.S. label). Those reforms will make it more difficult on people and business engaged in illegal, wholesale prescription drug importation. An earlier version of H.R. 6, from the House, included language that exempted imports for personal use. That language was quietly removed in a Senate version, which passed in that chamber. Then, apparently there was some protest among certain members of Congress and the language was put back in during conference – and is now in the final law.
Now I’m getting a lot of questions about the law and personal drug importation. There are several parts of law, regulation and policy very favorable to personal (but not wholesale) importation, which have yet to be compiled and addressed in one article. I endeavor to do that here. The gist is that Congress doesn’t want the FDA to unnecessarily stop Americans from buying medication from Canada and many other countries – even if it’s technically illegal. The position of Congress is clear in law if you look comprehensively and closely. (more…)
Tagged with: Congress, enforcement discretion, FDA, personal importation policy
The hearings on Capitol Hill about drug prices were a big deal this week. To policy wonks. All the rage was the report by the National Academies of Sciences about policies to lower drug prices. There was lot of intriguing discussion, debate, and deliberation on things we should do. Many that I agree with! Blah, blah, blah, blah. Medicare should negotiate drug prices! We should make generics available quicker! We should clamp down on patent abuse by big pharma! More price transparency! Stop direct-to-consumer advertising! Blah, blah, blah…blah. All of this was a big deal. To policy wonks.
What about people today?!??!
Now I like talking policy – too much sometimes. But I’m not writing about that hearing. No way. I came across a little piece in the New York Times, which loudly reminded me of this fact: While Congress debates, activists act, and policy nuts pontificate on drug prices –foreign pharmacies are the solution that saves American lives NOW. This is indisputable.
Access to more affordable drugs keeps Americans out of the hospital, able to lead more productive lives – and living. That’s what the most conclusive research proves.
For that reason: There’s no doubt in my mind that properly verified Canadian and other foreign online pharmacies are a boon to public health because they are far cheaper than U.S. pharmacies. Just to be clear: It’s not just that they help Americans save hundreds of millions of dollars a year – maybe billions (wish I knew). They are saving lives. (more…)
Tagged with: Commonwealth Fund, Congress, FDA, Hearings, Medication Adherence, National Academy of Sciences
Getting some prescription justice
This week, the group Prescription Justice sent a letter to Congress (House and Senate) signed by prominent non-profit activist and policy organizations – and PharmacyChecker.com (we were the only company!) – that clearly recognizes the lifeline of personal drug importation and the role that safe international online pharmacies play. The focus of the letter is support for the Affordable and Safe Prescription Drug Importation Act of 2017, which would help expand lawful options for importing lower cost medication, through retail and wholesale commerce. I wrote about this drug importation legislation a couple of months ago.
Too frequently I read articles in support or against drug importation that both drive me nuts. You’d think that I love the former and hate the latter but that’s not the case. I’m often equally annoyed when the authors either don’t know or care to write about the reality of prescription drug importation where people just go online, order their medication from Canada or another country, send in their valid prescriptions and get it by mail. As the letter iterates:
“Despite the federal restrictions, millions of Americans already import life-saving medications for their own use. While this practice can be done safely through properly credentialed international online pharmacies, it poses a real danger to patient safety because of rogue Internet drug sellers.”
And that’s why PharmacyChecker.com does what we do: verify and identify the safest international online options, educate and warn about rogue pharmacies, and get vocal about it. While the drug companies are obscenely powerful and are spending through the teeth to create anti-importation op-eds and reports, and giving members of Congress lots of money, the truth is a pretty powerful adversary as well. And importing medication from a licensed pharmacy in Canada (and many other countries) is, in the real world of facts, safe. (more…)
Tagged with: Congress, importation, letter, prescription justice